Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A reevaluation of the exclusion criteria used in antidepressant efficacy trials.

Posternak MA, Zimmerman M, Keitner GI, Miller IW.

Am J Psychiatry. 2002 Feb;159(2):191-200.

PMID:
11823258
2.

Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

Zimmerman M, Mattia JI, Posternak MA.

Am J Psychiatry. 2002 Mar;159(3):469-73.

PMID:
11870014
3.
4.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
5.

Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling.

Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D.

J Affect Disord. 2016 Jan 15;190:357-61. doi: 10.1016/j.jad.2015.10.041. Epub 2015 Oct 25. Review.

PMID:
26546771
6.

Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?

Weisberg HI, Hayden VC, Pontes VP.

Clin Trials. 2009 Apr;6(2):109-18. doi: 10.1177/1740774509102563.

PMID:
19342462
7.

Patients excluded from an antidepressant efficacy trial.

Partonen T, Sihvo S, Lönnqvist JK.

J Clin Psychiatry. 1996 Dec;57(12):572-5.

PMID:
9010119
8.

A review of the effectiveness of antidepressant medications for depressed nursing home residents.

Boyce RD, Hanlon JT, Karp JF, Kloke J, Saleh A, Handler SM.

J Am Med Dir Assoc. 2012 May;13(4):326-31. doi: 10.1016/j.jamda.2011.08.009. Epub 2011 Oct 21. Review.

9.

How Commonly Used Inclusion and Exclusion Criteria in Antidepressant Registration Trials Affect Study Enrollment.

Preskorn SH, Macaluso M, Trivedi M.

J Psychiatr Pract. 2015 Jul;21(4):267-74. doi: 10.1097/PRA.0000000000000082.

PMID:
26164052
10.

Relevance of exclusion criteria in antidepressant clinical trials: a replication study.

Zetin M, Hoepner CT.

J Clin Psychopharmacol. 2007 Jun;27(3):295-301.

PMID:
17502778
11.

Have Treatment Studies of Depression Become Even Less Generalizable? A Review of the Inclusion and Exclusion Criteria Used in Placebo-Controlled Antidepressant Efficacy Trials Published During the Past 20 Years.

Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D.

Mayo Clin Proc. 2015 Sep;90(9):1180-6. doi: 10.1016/j.mayocp.2015.06.016. Epub 2015 Aug 12. Review.

PMID:
26276679
13.

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.

Curr Med Res Opin. 2007 Feb;23(2):401-16.

PMID:
17288694
14.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
16.

How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial?

Keitner GI, Posternak MA, Ryan CE.

J Clin Psychiatry. 2003 Sep;64(9):1091-3.

PMID:
14628985
17.

Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis.

Iovieno N, Papakostas GI.

J Clin Psychiatry. 2012 Oct;73(10):1300-6. doi: 10.4088/JCP.11r07485. Review.

PMID:
23140647
18.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000031. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD000031.

PMID:
17253443
19.

Efficacy in long-term treatment of depression.

Montgomery SA.

J Clin Psychiatry. 1996;57 Suppl 2:24-30. Review.

PMID:
8626360
20.

The mousetrap: managing the placebo effect in antidepressant trials.

Lakoff A.

Mol Interv. 2002 Apr;2(2):72-6. Review. No abstract available.

PMID:
14993352

Supplemental Content

Support Center